Mutation of p53 gene are described in 25% of adenomas and in 50-70% of patients with CRC (Qie and Diehl, 2016) GC studies suggest that patients with no p53 expression have a higher survival rate in relation to patients who have the mutation of this protein (Motokura et al., 2003 ). This evidence concerns the gene TP53 and adenoma.